Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $37,345 | 2,453 | 98.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $434.56 | 22 | 1.1% |
| Education | $68.36 | 8 | 0.2% |
| Gift | $58.54 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $4,679 | 398 | $0 (2024) |
| UCB, Inc. | $3,222 | 171 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $2,574 | 213 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $1,854 | 125 | $0 (2024) |
| ABBVIE INC. | $1,614 | 110 | $0 (2024) |
| Neurelis, Inc. | $1,436 | 55 | $0 (2024) |
| Acorda Therapeutics, Inc | $1,184 | 61 | $0 (2023) |
| Amneal Pharmaceuticals LLC | $1,173 | 84 | $0 (2024) |
| PFIZER INC. | $1,039 | 90 | $0 (2024) |
| Lilly USA, LLC | $1,024 | 83 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,942 | 305 | MDD US Operations, LLC ($511.01) |
| 2023 | $5,295 | 296 | Neurocrine Biosciences, Inc. ($860.84) |
| 2022 | $5,158 | 354 | ABBVIE INC. ($563.15) |
| 2021 | $5,572 | 425 | Teva Pharmaceuticals USA, Inc. ($1,095) |
| 2020 | $5,531 | 402 | Teva Pharmaceuticals USA, Inc. ($1,006) |
| 2019 | $5,529 | 378 | Teva Pharmaceuticals USA, Inc. ($1,608) |
| 2018 | $2,382 | 145 | UCB, Inc. ($268.08) |
| 2017 | $2,497 | 181 | Sunovion Pharmaceuticals Inc. ($264.38) |
All Payment Transactions
2,486 individual payment records from CMS Open Payments — Page 1 of 100
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Neuromodulation | ||||||
| 12/27/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 12/20/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: PAIN | ||||||
| 12/19/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Neurology | ||||||
| 12/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: PAIN | ||||||
| 12/17/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Central Nervous System | ||||||
| 12/16/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 12/16/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/16/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $5.38 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/14/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $32.44 | General |
| Category: EPILEPSY | ||||||
| 12/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Lilly USA, LLC | EMGALITY (Drug), KISUNLA | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Neuroscience | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $35.48 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $23.17 | General |
| Category: NEUROLOGY | ||||||
| 12/09/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Neuromodulation | ||||||
| 12/07/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $31.33 | General |
| Category: Neurology | ||||||
| 12/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: PAIN | ||||||
| 12/04/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $40.69 | General |
| Category: Neurology | ||||||
| 12/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: PAIN | ||||||
| 11/25/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 763 | 1,160 | $240,355 | $106,629 |
| 2022 | 11 | 736 | 1,009 | $205,370 | $90,193 |
| 2021 | 9 | 836 | 1,176 | $227,595 | $107,112 |
| 2020 | 10 | 883 | 1,227 | $234,800 | $97,852 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 239 | 475 | $85,595 | $42,669 | 49.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 135 | 135 | $37,125 | $15,872 | 42.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 90 | 208 | $36,400 | $15,282 | 42.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 168 | 210 | $25,200 | $12,518 | 49.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 42 | 43 | $19,350 | $6,644 | 34.3% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 30 | 30 | $15,000 | $5,669 | 37.8% |
| 95724 | Measurement of brain wave activity with video (veeg), 61-84 hours with review and report by health care professional | Office | 2023 | 11 | 11 | $7,480 | $2,678 | 35.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $4,380 | $1,844 | 42.1% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 15 | 15 | $5,625 | $1,745 | 31.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $4,200 | $1,706 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 171 | 275 | $49,500 | $25,189 | 50.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 216 | 291 | $34,920 | $16,717 | 47.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 88 | 182 | $31,850 | $13,993 | 43.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 121 | 121 | $33,275 | $13,625 | 40.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 49 | 49 | $22,050 | $7,451 | 33.8% |
| 95724 | Measurement of brain wave activity with video (veeg), 61-84 hours with review and report by health care professional | Office | 2022 | 12 | 12 | $8,160 | $2,998 | 36.7% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 15 | 15 | $7,500 | $2,599 | 34.7% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 20 | 20 | $7,500 | $2,583 | 34.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $4,015 | $1,867 | 46.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $4,400 | $1,638 | 37.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 11 | $2,200 | $1,531 | 69.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 183 | 323 | $54,510 | $30,096 | 55.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 187 | 187 | $51,425 | $22,213 | 43.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 244 | 342 | $38,920 | $20,612 | 53.0% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 81 | 183 | $32,025 | $14,709 | 45.9% |
About Dr. Toan Vu, M.D
Dr. Toan Vu, M.D is a Neurology healthcare provider based in San Marcos, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1760463293.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Toan Vu, M.D has received a total of $37,906 in payments from pharmaceutical and medical device companies, with $5,942 received in 2024. These payments were reported across 2,486 transactions from 77 companies. The most common payment nature is "Food and Beverage" ($37,345).
As a Medicare-enrolled provider, Vu has provided services to 3,218 Medicare beneficiaries, totaling 4,572 services with total Medicare billing of $401,787. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location San Marcos, TX
- Active Since 11/10/2005
- Last Updated 07/23/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1760463293
Products in Payments
- NUPLAZID (Drug) $2,574
- AUSTEDO (Drug) $1,907
- VALTOCO (Drug) $1,436
- AJOVY (Biological) $1,390
- INGREZZA (Drug) $1,287
- Briviact (Drug) $1,275
- RYTARY (Drug) $1,254
- AJOVY (Drug) $1,167
- Vimpat (Drug) $1,138
- INBRIJA (Drug) $1,028
- UBRELVY (Drug) $880.85
- NURTEC ODT (Drug) $862.41
- EMGALITY (Drug) $743.24
- GOCOVRI (Drug) $690.80
- Aimovig (Biological) $621.55
- Neupro (Drug) $620.37
- NOURIANZ (Drug) $614.87
- TROKENDI XR (Drug) $606.11
- INFINITY (Device) $575.51
- Gocovri (Drug) $511.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.